NXU

(2R,4S)-2-[(1R)-2-hydroxy-1-{[(2-hydroxynaphthalen-1-yl)carbonyl]amino}ethyl]-5,5-dimethyl-1,3-thiazolidine-4-carboxylic acid

Created:	2014-09-12
Last modified:	2024-09-27

Find Related PDB Entry
1 entries where NXU is covalently linked to polymer or other heterogen groups

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	49
Chiral Atom Count	3
Bond Count	51
Aromatic Bond Count	11

2D diagram of NXU

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	(2R,4S)-2-[(1R)-2-hydroxy-1-{[(2-hydroxynaphthalen-1-yl)carbonyl]amino}ethyl]-5,5-dimethyl-1,3-thiazolidine-4-carboxylic acid
Systematic Name (OpenEye OEToolkits)	(2R,4S)-5,5-dimethyl-2-[(1R)-2-oxidanyl-1-[(2-oxidanylnaphthalen-1-yl)carbonylamino]ethyl]-1,3-thiazolidine-4-carboxylic acid
Formula	C₁₉ H₂₂ N₂ O₅ S
Molecular Weight	390.453
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	ACDLabs	12.01	O=C(NC(C1SC(C(N1)C(=O)O)(C)C)CO)c3c2ccccc2ccc3O
SMILES	CACTVS	3.385	CC1(C)S[CH](N[CH]1C(O)=O)[CH](CO)NC(=O)c2c(O)ccc3ccccc23
SMILES	OpenEye OEToolkits	1.7.6	CC1(C(NC(S1)C(CO)NC(=O)c2c3ccccc3ccc2O)C(=O)O)C
Canonical SMILES	CACTVS	3.385	CC1(C)S[C@@H](N[C@H]1C(O)=O)[C@@H](CO)NC(=O)c2c(O)ccc3ccccc23
Canonical SMILES	OpenEye OEToolkits	1.7.6	CC1([C@@H](N[C@H](S1)[C@@H](CO)NC(=O)c2c3ccccc3ccc2O)C(=O)O)C
InChI	InChI	1.03	InChI=1S/C19H22N2O5S/c1-19(2)15(18(25)26)21-17(27-19)12(9-22)20-16(24)14-11-6-4-3-5-10(11)7-8-13(14)23/h3-8,12,15,17,21-23H,9H2,1-2H3,(H,20,24)(H,25,26)/t12-,15+,17-/m1/s1
InChIKey	InChI	1.03	BZLDRFAHCQLJIH-ISTRZQFTSA-N

Related Resource References

Resource Name	Reference
PubChem	137349816

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.